Keymed Biosciences Inc. (2162.HK) News
Follow Keymed Biosciences Inc. (2162.HK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BREAKINGVIEWS — China biotech's ingenuity extends to dealmaking
(The author is a Reuters Breakingviews columnist. The opinions expressed are her own.) By Katrina Hamlin HONG KONG, Oct 16 (Reuters Breakingviews) — Chinese drugmakers' 2026 overseas licensing deals just hit $139 bln, be
GEOPOLITICS | Oct 16, 2026, 04:22 AM UTC
L
BUZZ — Keymed Biosciences hits near 3 — month high on product revenue growth
* Shares of Keymed Biosciences jump 12.5% to HK$85.7, their highest level since July 24 * Stock of biological therapies developer on course for biggest one-day pct rise since June 29 after three consecutive sessions of f
GEOPOLITICS | Oct 16, 2026, 02:29 AM UTC